Mitochondrial Damage: A Target for New Therapeutic Horizons

Soustiel, Jean F.; Larisch, Sarit
January 2010
Neurotherapeutics;Jan2010, Vol. 7 Issue 1, p13
Academic Journal
journal article
Summary: Traumatic brain injury (TBI) represents a leading cause of death and morbidity, as well as a considerable social and economical burden in western countries, and has thus emerged as a formidable therapeutic challenge. Yet despite tremendous efforts enlightening the mechanisms of neuronal death, hopes for the “magic bullet” have been repeatedly deceived, and TBI management has remained focused on the control of increased intracranial pressure. Indeed, impairment of cerebral metabolism is traditionally attributed to impaired oxygen delivery mediated by reduced cerebral perfusion in the swollen cerebral parenchyma. Although intuitively appealing, this hypothesis is not entirely supported by physiological facts and does not take into consideration mitochondrial dysfunction that has been repeatedly reported in both human and animal TBI. Although the nature and origin of the events leading to mitochondrial damage may be different, most share a permeabilization of mitochondrial membrane, which therefore may represent a logical target for new therapeutic strategies. Therefore, the proteins mediating these events may represent promising targets for new TBI therapies. Furthermore, mimicking anti-apoptotic proteins, such as Bcl-2 or XIAP, or inhibiting mitochondrial pro-apoptotic proteins, such as Smac/DIABLO, Omi/HTRA2, and ARTS (septin 4 isoform 2) may represent useful novel therapeutic strategies. This review focuses on mechanisms of the mitochondrial membrane permeabilization and its consequences and discusses the current and possible future therapeutic implications of this key event of neuronal death.


Related Articles

  • Upstream control of apoptosis by caspase-2 in serum-deprived primary neurons. Chauvier, D.; Lecoeur, H.; Langonn&a#x00E9;, A.; Borgne-Sanchez, A.; Mariani, J.; Martinou, J.-C.; Rebouillat, D.; Jacotot, E. // Apoptosis;Nov2005, Vol. 10 Issue 6, p1243 

    During development as well as in pathological situations, neurons that fail to find appropriate targets or neurotrophic factors undergo cell death. Using primary cortical neurons subjected to acute serum-deprivation (SD), we have examined caspases activation, mitochondrial dysfunction and cell...

  • The mitochondrial permeability transition pore: a mystery solved? Bernardi, Paolo // Frontiers in Physiology;May2013, Vol. 4, p1 

    The permeability transition (PT) denotes an increase of the mitochondrial inner membrane permeability to solutes with molecular masses up to about 1500 Da. It is presumed to be mediated by opening of a channel, the permeability transition pore (PTP), whose molecular nature remains a mystery....

  • The Pathological Roles of Ganglioside Metabolism in Alzheimer's Disease: Effects of Gangliosides on Neurogenesis. Ariga, Toshio; Wakade, Chandramohan; Yu, Robert K. // International Journal of Alzheimer's Disease;2011, Vol. 2011, p1 

    Conversion of the soluble, nontoxic amyloid β-protein (Aβ) into an aggregated, toxic form rich in β-sheets is a key step in the onset of Alzheimer's disease (AD). It has been suggested that Aβ induces changes in neuronal membrane fluidity as a result of its interactions with membrane...

  • Alteration of the nuclear pore complex in Ca2+-mediated cell death. Bano, D.; Dinsdale, D.; Cabrera-Socorro, A.; Maida, S.; Lambacher, N.; Mccoll, B.; Ferrando-May, E.; Hengartner, M. O.; Nicotera, P. // Cell Death & Differentiation;Jan2010, Vol. 17 Issue 1, p119 

    Cell death requires coordinated intracellular signalling before disassembly of cell architecture by degradative enzymes. Although the death signalling cascades that involve the mitochondria, the ER and the plasma membrane have been extensively characterized, only a handful of studies have...

  • Bax targeting to mitochondria occurs via both tail anchor-dependent and -independent mechanisms. Valentijn, A. J.; Upton, J.-P.; Bates, N.; Gilmore, A. P. // Cell Death & Differentiation;Aug2008, Vol. 15 Issue 8, p1243 

    Bax is a member of the Bcl-2 family that, together with Bak, is required for permeabilisation of the outer mitochondrial membrane (OMM). Bax differs from Bak in that it is predominantly cytosolic in healthy cells and only associates with the OMM after an apoptotic signal. How Bax is targeted to...

  • Differential gene expression during apoptosis induced by a serum factor: Role of mitochondrial F0-F1 ATP synthase complex. Singh, S.; Khar, A. // Apoptosis;Nov2005, Vol. 10 Issue 6, p1469 

    The number of genes that are up regulated or down regulated during apoptosis is large and still increasing. In an attempt to characterize differential gene expression during serum factor induced apoptosis in AK-5 cells (a rat histiocytoma), we found subunit 6 and subunit 8 of the transmembrane...

  • Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm. Lee, S-H; Meng, X W; Flatten, K S; Loegering, D A; Kaufmann, S H // Cell Death & Differentiation;Jan2013, Vol. 20 Issue 1, p64 

    Phosphatidylserine (PS) exposure on the external leaflet of the plasma membrane is widely observed during apoptosis and forms the basis for the annexin V binding assay to detect apoptotic cell death. Current efforts to explain PS exposure focus on two potential mechanisms, activation of a...

  • ARF1 is directly involved in dynamin-independent endocytosis. Kumari, Sudha; Mayor, Satyajit // Nature Cell Biology;Jan2008, Vol. 10 Issue 1, p30 

    Endocytosis of glycosylphosphatidyl inositol (GPI)-anchored proteins (GPI-APs) and the fluid phase takes place primarily through a dynamin- and clathrin-independent, Cdc42-regulated pinocytic mechanism. This mechanism is mediated by primary carriers called clathrin-independent carriers (CLICs),...

  • Formation of Toxic Amyloid Fibrils by Amyloid β-Protein on Ganglioside Clusters. Matsuzaki, Katsumi // International Journal of Alzheimer's Disease;2011, Vol. 2011, p1 

    It is widely accepted that the conversion of the soluble, nontoxic amyloid β-protein (Aβ) monomer to aggregated toxic Aβ rich in β-sheet structures is central to the development of Alzheimer's disease. However, the mechanism of the abnormal aggregation of Aβ in vivo is not well...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics